Online Exclusive Article

Factors Influencing Oncology Nurses' Use of Hazardous Drug Safe-Handling Precautions

Martha Polovich

Patricia C. Clark

safety, hazardous substances
ONF 2012, 39(3), E299-E309. DOI: 10.1188/12.ONF.E299-E309

Purpose/Objectives: To examine relationships among factors affecting nurses' use of hazardous drug (HD) safe-handling precautions, identify factors that promote or interfere with HD precaution use, and determine managers' perspectives on the use of HD safe-handling precautions.

Design: Cross-sectional, mixed methods; mailed survey to nurses who handle chemotherapy and telephone interviews with managers.

Setting: Mailed invitation to oncology centers across the United States.

Sample: 165 nurses who reported handling chemotherapy and 20 managers of nurses handling chemotherapy.

Methods: Instruments measured the use of HD precautions and individual and organizational factors believed to influence precaution use. Data analysis included descriptive statistics and hierarchical regression. Manager interview data were analyzed using content analysis.

Main Research Variables: Chemotherapy exposure knowledge, self-efficacy, perceived barriers, perceived risk, interpersonal influences, and workplace safety climate.

Findings: Nurses were well educated, experienced, and certified in oncology nursing. The majority worked in outpatient settings and administered chemotherapy to an average of 6.8 patients per day. Exposure knowledge, self-efficacy for using personal protective equipment, and perceived risk of harm from HD exposure were high; total precaution use was low. Nurse characteristics did not predict HD precaution use. Fewer barriers, better workplace safety climate, and fewer patients per day were independent predictors of higher HD precaution use. HD handling policies were present, but many did not reflect current recommendations. Few managers formally monitored nurses' HD precaution use.

Conclusions: Circumstances in the workplace interfere with nurses' use of HD precautions.

Implications for Nursing: Interventions should include fostering a positive workplace safety climate, reducing barriers, and providing appropriate nurse-patient ratios.

Jump to a section

    References

    American Society of Health System Pharmacists. (2006). ASHP guidelines on handling hazardous drugs. American Journal of Health-System Pharmacy, 63, 1172-1193. doi:10.2146/ajhp050529
    Bureau of Labor Statistics. (2010). Occupational employment and wages, May 2010: 29-0000 healthcare practitioners and technical occupations (major group). Retrieved from http://www.stats.bls.gov/oes/current/oes290000.htm
    Cooper, M. D., & Phillips, R. A. (2004). Exploratory analysis of the safety climate and safety behavior relationship. Journal of Safety Research, 35, 497-512.
    DeJoy, D. M., Gershon, R. R. M., & Schaffer, B. S. (2004, July). Safety climate: Assessing management and organizational influences on safety. Professional Safety, 50-57.
    DeJoy, D. M., Murphy, L. R., & Gershon, R. R. M. (1995). The influence of employee, job/task, and organizational factors on adherence to universal precautions among nurses. International Journal of Industrial Ergonomics, 16, 43-55. doi:10.1016/0169-8141(94)00075-E
    DeJoy, D. M., Searcy, C. A., Murphy, L. R., & Gershon, R. R. (2000). Behavioral-diagnostic analysis of compliance with universal precautions among nurses. Journal of Occupational Health Psychology, 5, 127-141.
    Dillman, D. A. (2007). Mail and Internet surveys: The Tailored Design Method (2nd ed.). Hoboken, NJ: John Wiley and Sons.
    Faul, F., Erdfelder, E., Lang, A. G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39, 175-191. doi:10.3758/BF03193146
    Fransman, W., Roeleveld, N., Peelen, S., de Kort, W., Kromhout, H., & Heederik, D. (2007). Nurses with dermal exposure to antineoplastic drugs: Reproductive outcomes. Epidemiology, 18, 112-119. doi:10.1097/01.ede.0000246827.44093.c1
    Friese, C. R., Himes-Ferris, L., Frasier, M. N., McCullagh, M. C., & Griggs, J. J. (2011). Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy. BMJ Quality and Safety. Advance online publication. doi:10.1136/bmjqs-2011-000178
    Fuchs, J., Hengstler, J. G., Jung, D., Hiltl, G., Konietzko, J., & Oesch, F. (1995). DNA damage in nurses handling antineoplastic agents. Mutation Research, 342, 17-23. doi:10.1016/0165-1218(95)90086-1
    Geer, L. A., Anna, D. H., Curbow, B. A., Diener-West, M., de Joode, B. W., Mitchell, C. S., & Buckley, T. J. (2007). Survey assessment of worker dermal exposure and underlying behavioral determinants. Journal of Occupational and Environmental Hygiene, 4, 809-820. doi:10.1080/15459620701612722
    Geer, L. A., Curbow, B. A., Anna, D. H., Lees, P. S. J., & Buckley, T. J. (2006). Development of a questionnaire to assess worker knowledge, attitudes and perceptions underlying dermal exposure. Scandinavian Journal of Work and Environmental Health, 32, 209-218.
    Gershon, R. R. M., Karkashian, C. D., Grosch, J. W., Murphy, L. R., Escamilla-Cejudo, A., Flanagan, P. A., … Martin, L. (2000). Hospital safety climate and its relationship with safe work practices and workplace exposure incidents. American Journal of Infection Control, 28, 211-221.
    Gershon, R. R. M., Mitchell, C. S., Sherman, M. F., Vlahov, D., Lears, M. K., Felknor, S. A., & Lubelczyk, R. A. (2005). Hepatitis B vaccination in correctional health care workers. American Journal of Infection Control, 33, 510-518. doi:10.1016/j.ajic.2005.04.245
    Gershon, R. R. M., Qureshi, K. A., Pogorzelska, B. A., Rosen, J., Gebbie, K. M., Brandt-Rauf, P., & Sherman, M. F. (2007). Non-hospital based registered nurses and the risk of bloodborne pathogen exposure. Industrial Health, 45, 695-704. doi:10.2486/indhealth.45.695
    Gershon, R. R. M., Stone, P. W., Bakken, S., & Larson, E. (2004). Measurement of organizational culture and climate in healthcare. Journal of Nursing Administration, 34, 33-40.
    Gershon, R. R. M., Vlahov, D., Felknor, S. A., Vesley, D., Johnson, P. C., Delclos, G. L., & Murphy, L. R. (1995). Compliance with universal precautions among health care workers at three regional hospitals. American Journal of Infection Control, 23, 225-236. doi:10.1016/0196-6553(95)90067-5
    Grosch, J. W., Gershon, R. R. M., Murphy, L. R., & DeJoy, D. M. (1999). Safety climate dimensions associated with occupational exposure to blood-borne pathogens in nurses. American Journal of Industrial Medicine, 36(Suppl. 1), 122-124. doi:10.1002/(SICI)1097-0274(199909)36:1+<122::AID-AJIM43>3.0.CO;2-L
    Hansen, J., & Olsen, J. H. (1994). Cancer morbidity among Danish female pharmacy technicians. Scandinavian Journal of Work and Environmental Health, 20, 22-26.
    Harrison, B. R. (2001). Risks of handling cytotoxic drugs. In M. C. Perry (Ed.), The chemotherapy source book (3rd ed., pp. 566-582). Philadelphia, PA: Lippincott, Williams and Wilkins.
    Lusk, S. L., Ronis, D. L., & Hogan, M. M. (1997). Test of the health promotion model as a causal model of construction workers' use of hearing protection. Research in Nursing and Health, 20, 183-194.
    Mahon, S. M., Casperson, D. S., Yackzan, S., Goodner, S., Hasse, B., Hawkins, J., … Witcher, V. (1994). Safe handling practices of cytotoxic drugs: The results of a chapter survey. Oncology Nursing Forum, 21, 1157-1165.
    Martin, S. (2003). Chemotherapy handling and effects among nurses and their offspring (Doctoral dissertation). Columbia University, New York, NY.
    Martin, S., & Larson, E. (2003). Chemotherapy-handling practices of outpatient and office-based oncology nurses. Oncology Nursing Forum, 30, 575-581. doi:10.1188/03.ONF.575-581
    McCullagh, M., Lusk, S. L., & Ronis, D. L. (2002). Factors influencing use of hearing protection among farmers: A test of the Pender Health Promotion Model. Nursing Research, 51, 33-39. doi:10.1097/00006199-200201000-00006
    McDiarmid, M. A., Oliver, M. S., Roth, T. S., Rogers, B., & Escalante, C. (2010). Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. Journal of Occupational and Environmental Medicine, 52, 1028-1034. doi:10.1097/JOM.0b013e3181f73ae6
    Moore, D., Gamage, B., Bryce, E., Copes, R., Yassi, A., & BC Interdisciplinary Respiratory Protection Study Group. (2005). Protecting health care workers from SARS and other respiratory pathogens: Organizational and individual factors that affect adherence to infection control guidelines. American Journal of Infection Control, 33(2), 88-96. doi:10.1016/j.ajic.2004.11.003
    National Institute for Occupational Safety and Health. (2004). Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. Retrieved from http://www.cdc.gov/niosh/docs/2004-165
    Nieweg, R. M., de Boer, M., Dubbleman, R. C., Gall, H. E., Hesselman, G. M., Lenssen, P. C., … Slegt, J. H. (1994). Safe handling of antineoplastic drugs: Results of a survey. Cancer Nursing, 17, 501-511. doi:10.1097/00002820-199412000-00008
    Occupational Safety and Health Administration. (1986). OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. American Journal of Hospital Pharmacy, 43(Appendix 7), 1193-1204.
    Occupational Safety and Health Administration. (1999). Controlling occupational exposure to hazardous drugs. Retrieved from http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html
    Occupational Safety and Health Administration. (2004). Code of federal regulations. Title 29, labor. Retrieved from http://www.access.gpo.gov/nara/cfr/waisidx_04/29cfr1910_04.html
    Pender, N. J., Murdaugh, C., & Parsons, M. A. (Eds.). (2006). Health promotion in nursing practice (5th ed.). Upper Saddle River, NJ: Prentice Hall.
    Peterson, S. J., & Bredow, T. S. (Eds.). (2004). Middle-range theories: Application to nursing research. Philadelphia, PA: Lippincott, Williams and Wilkins.
    Polit, D. F., Beck, C. T., & Owen, S. V. (2007). Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Research in Nursing and Health, 30, 459-467.
    Polovich, M., & Martin, S. (2011). Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines. Oncology Nursing Forum, 38, 718-726. doi:10.1188/11.ONF.718-726
    Polovich, M., Whitford, J. M., & Olsen, M. (Eds.). (2009). Chemotherapy and biotherapy guidelines and recommendations for practice (3rd ed.). Pittsburgh, PA: Oncology Nursing Society.
    Skov, T., Maarup, B., Olsen, J., Rorth, M., Winthereik, H., & Lynge, E. (1992). Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. British Journal of Industrial Medicine, 49, 855-861. doi:10.1136/oem.49.12.855
    Stajicj, G. V., Barnett, C. W., Turner, S. V., & Henderson, C. A. (1986). Protective measures used by oncologic office nurses handling parenteral antineoplastic agents. Oncology Nursing Forum, 13, 47-49.
    Testa, A., Gianchelia, M., Palma, S., Appolloni, M., Padua, L., Tranfo, G., … Cozzi, R. (2007). Occupational exposure to antineoplastic agents induces a high level of chromosome damage. Lack of an effect of GST polymorphisms. Toxicology and Applied Pharmacology, 223, 46-55. doi:10.1016/j.taap.2007.05.006
    Valanis, B., McNeil, V., & Driscoll, K. (1991). Staff members' compliance with their facility's antineoplastic drug handling policy. Oncology Nursing Forum, 18, 571-576.
    Valanis, B., & Shortridge, L. (1987). Self protective practices of nurses handling antineoplastic drugs. Oncology Nursing Forum, 14(3), 23-27.
    Valanis, B., Vollmer, W. M., Labuhn, K., & Glass, A. (1993a). Acute symptoms associated with antineoplastic drug handling among nurses. Cancer Nursing, 16, 288-295. doi:10.1097/00002820-199308000-00005
    Valanis, B., Vollmer, W. M., Labuhn, K., & Glass, A. (1993b). Association of antineoplastic drug handling with acute adverse effects in pharmacy personnel. American Journal of Hospital Pharmacy, 50, 455-462.
    Valanis, B., Vollmer, W. M., Labuhn, K., & Glass, A. (1997). Occupational exposure to antineoplastic agents and self-reported infertility among nurses and pharmacists. Journal of Occupational and Environmental Medicine, 39, 574-580. doi:10.1097/00043764-199706000-00013
    Yoshida, J., Kosaka, H., Tomika, K., & Kumagai, S. (2006). Genotoxic risks to nurses from contamintion of the work environment with antineoplastic drugs in Japan. Journal of Occupational Health, 48, 517-522. doi:10.1539/joh.48.517